U.S. flag

An official website of the United States government

Figure 1

Figure 1. From: Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.

Two-dimensional gel electrophoresis of the plasma proteome. (A) Position of protein spots most significantly influenced by the initial dose of the therapy on a representative 2D-gel image. Their molecular identity is indicated in . The underlined numbers represent members of the complement system. (B and C) show 2D-western blot images using antibodies against complement component C3 (B) or C4 (C). The detail displayed in the punctured frame shows the signals obtained by incubation with monoclonal anti-C4d antibody. Only this antibody recognised the upper C4 α-chain. Protein spots indicated in rectangles represent complement isoforms that are significantly differentially influenced by the initial dose between responders and non-responders.

A Michlmayr, et al. Br J Cancer. 2010 Oct 12;103(8):1201-1208.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center